MALVERN, Pa., October 26, 2023 — LifeSensors, Inc., a leading innovator in protein degradation technologies, has been invited to speak at the 6th Annual Targeted Protein Degradation Summit 2023 in…
Read More
[Malvern, PA, October 18, 2023] — LifeSensors Inc., a biotech company targeting the ubiquitin proteasome system for drug discovery and diagnostic markers, has received funding from the National Institute on...
Read More
MALVERN, Pa., SEP 21, 2023 — LifeSensors Inc., a Biotech and Drug Discovery Company focused on PROTAC, molecular glue drug discovery and neurodegeneration diagnostics has been invited to speak at the…
MALVERN, PA., May 30, 2023 — LifeSensors Inc., a Biotech and Drug Discovery Company focused on PROTACs, molecular glues, and neurodegeneration diagnostics will disclose direct methods to detect PROTAC & molecular glue…
LifeSensors is Attending ASCB | EMBO Cell Bio 2022 MALVERN, PA., AUG 30, 2022 -- LifeSensors Inc., a Biotech and Drug Discovery Company focused on PROTACs, molecular glues, and neurodegeneration...
Read More
LifeSensors Invited to Speak at the Industry’s Preeminent 20th Annual Discovery on Target Conference
LifeSensors Invited to Speak at the Industry’s Preeminent 20th Annual Discovery on Target Conference MALVERN, Pa., AUG 30, 2022 -- LifeSensors Inc., a Biotech and Drug Discovery Company focused on...
Read More
LifeSensors Attending the 5th Annual Targeted Protein Degradation Summit MALVERN, PA., AUG 30, 2022 -- LifeSensors Inc., a Biotech and Drug Discovery Company focused on PROTAC, Molecular Glues, and neurodegeneration...
Read More
DTE proteins, or ‘difficult-to-express’ proteins are a common hurdle for researchers in the lab. Due to difficulty with correct protein folding and general protein synthesis success, coronavirus proteins find themselves…
LifeSensors is happy to say we’re growing! We’ve always been one to say more the merrier, and now we truly are. With Axxora, we can offer near-complete global availability to...
Read More
FDA Provisional Approval LifeSensors is proud to announce its provisional FDA approval for our COVID-19 IgG ELISA Detection Kit to address the critical need for COVID-19 diagnostics through serological testing….